Ads
related to: medicine, pharmaceuticalsthomasnet.com has been visited by 10K+ users in the past month
Search results
European pharma regulation changes signal tumult and transformation
Pharmaceutical Technology via Yahoo Finance· 1 hour agoThe two main tracks of regulation on everyone’s minds were the revised General Pharmaceutical...
Veeva R&D Summit: Pharma companies need a say in AI regulation
Clinical Trials Arena via Yahoo Finance· 2 hours ago“As a result, it is important that everyone works together to at least share our views on this.” In...
Henan Lingrui Pharmaceutical Leads Three Key Dividend Stocks In China
Simply Wall St. via Yahoo Finance· 14 hours agoAs global markets grapple with mixed economic signals, China's equity landscape remains a focal...
Shares in Wegovy-maker Novo Nordisk climb, touching record high levels By Investing.com
Investing.com· 1 hour agoThe Danish pharmaceutical giant has seen its share price surge by more than 38% so far this year...
Insider Sale: EVP & CFO Charles F. Wagner Jr. Sells Shares of Vertex Pharmaceuticals Inc (VRTX) By...
Investing.com· 19 hours agoAccording to the SEC Filing, the transaction was executed at a stock price of $460, totaling...
Merck opens $195.7m expanded distribution centre in Germany
Pharmaceutical Technology via Yahoo Finance· 1 hour ago“This is critical to ensuring that medicines reach patients faster, safely and more efficiently....
In China, weight-loss drugs are becoming big business
Al Jazeera· 9 hours agoOzempic is big business in China. Last year, the Danish pharmaceutical giant Novo Nordisk doubled...
Could AI put an end to animal testing?
BBC via Yahoo News· 2 hours agoShe explains that new medicines are currently first tested both on rats and dogs to check for potential toxicity, before human trials potentially start....
Aurinia reports improved lupus nephritis therapy outcomes By Investing.com
Investing.com· 18 hours agoROCKVILLE, Md. & EDMONTON, Alberta - Aurinia Pharmaceuticals Inc. (NASDAQ: NASDAQ:AUPH) shared...
Evercore ISI cuts Editas Medicine stock target By Investing.com
Investing.com· 7 days agoOn Thursday, Evercore ISI adjusted its outlook on Editas Medicine (NASDAQ:EDIT), a biotechnology...
